Streptokinase
As of the edition of 20 October 2026, Streptokinase is an enzyme: marketed, first approved in 1965 (ES); acts on PLG.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1965
- Kind
- Enzyme
- Brand name
- Varidasa
- First approved
- 1 June 1965 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Industrial Farmaceutica Cantabria S.A.
- Registered trials
- 12, 2 stopped early
- Disease areas
- Heart and blood vessels; Lungs and airways; Digestive system; Infections; Nervous system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| PLG | Plasminogen [Cleaved into: Plasmin | P00747 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 0 | 1 | 1 |
| Phase 2 | 1 | 0 | 0 | 1 |
| Phase 3 | 5 | 5 | 0 | 0 |
| Phase 4 | 4 | 3 | 0 | 0 |
| All trials | 12 |